Pregenerate, Inc. provides products and services to replace expensive and inefficient animal testing in medical and pharmaceutical research.
Currently Pregenerate Inc. is focusing on global degenerative joint disease, osteoarthritis, which not only affects the aging human population but also sport horses and our beloved companion animals.
We use scaleable organ-on-a-chip models to replace animal testing in pharmaceutical research for arthritis treatments. This enables pharmaceutical companies to save billions of dollars and improve the success rates of their drugs to market, in part because we can use human cells in our model.
Ultimately, this same technology will allow us to stratify patients into targeted treatment subgroups, and even to tell each clinical patient what the best treatment is for his or her specific arthritis needs directly.
Company Details
- Employees
- 3
- Address
- Dr Bohr Gasse 7, 311,austria
- ju****@****ate.net
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pregenerate.net
- Keywords
- organ-on-chip, osteoarthritis, precision medicine, LDT, IVD test, biomarkers, gene expression analysis, arthritis, regenerative medicine, personalized care.
- HQ
- Vienna
Pregenerate Inc. Questions
Pregenerate Inc.'s website is pregenerate.net
Pregenerate Inc.'s LinkedIn profile is https://at.linkedin.com/company/pregenerate-inc
Pregenerate Inc. has
3 employees.
View email and phone details for 3
employees at Pregenerate Inc..
Pregenerate Inc.'s industry is
Biotechnology Research
Pregenerate Inc.'s top competitors are
A:head Bio Ag,
Aitiologic,
Lifetaq-Analytics Gmbh,
Myelopro Diagnostics And Research Gmbh,
Tamirna Gmbh,
Quaregia Gmbh - Quality & Regulatory Compliance,
Velalabs,
Virusure Gmbh,
Akribes Biomedical Gmbh,
Oncoone.
Pregenerate Inc.'s support email address is julie@pregenerate.net
Pregenerate Inc.'s categories are Biotechnology Research
